Top 10 High Tech Stocks To Buy Right Now

Related CHU Benzinga's Top Upgrades Benzinga's Top Upgrades
Related AAPL Apple Puts In Triple Top And Backs Off: Normal For A Pre-Earnings Run? Mid-Day Market Update: Badger Meter Rises Following Earnings Beat; Netflix Shares Drop All eyes back on Project Titan with German lab and Tesla hire in the mix (Seeking Alpha)

Seven years ago, China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU) solidified a deal with Apple Inc. (NASDAQ: AAPL) to bring iPhones to China.

Over the past 10 years, China Unicom has risen more than 50 percent. However, shorter-term, the telecom service provider has seen much more volatility. Looking at the five-year chart, the stock is down roughly 35 percent. For the year-to-date period, the stock is up 5 percent; however, over the past full year, the stock is down almost 27 percent.

Top 10 High Tech Stocks To Buy Right Now: AZZ Inc.(AZZ)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “AZZ Incorporated (AZZ) Receives Average Rating of “Hold” from Brokerages” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3371765/azz-incorporated-azz-receives-average-rating-of-hold-from-brokerages.html.

  • [By Garrett Baldwin]

    Money MorningDirector of Technology & Venture Capital Research Michael A. Robinson has brought our readers some of the best ways to make money on technology stocks. But there’s always been one company that he’s largely avoided over his career… until now. You’re not going to believe what U.S. tech firm Michael says will unleash a wave of profits on investors in the future. Find out here.

    Four Stocks to Watch Today: FB, TSLA, JPM, WFC
    Facebook Inc. (Nasdaq: FB) CEO Mark Zuckerberg will appear before a joint hearing of the Senate Judiciary and Commerce committee. Congress is investigating the data scraping efforts of Cambridge Analytica, which have brought a significant amount of embarrassment to the social media giant. Congress will be asking questions about the firm’s privacy practices in the wake of the policy that allowed Cambridge Analytica to obtain the personal information of roughly 87 million users. Shares of Tesla Inc. (Nasdaq: TSLA) made small gains after the announcement by China’s president to cut import tariffs. But there was a second factor that provided investor enthusiasm this morning. The head of the National Transportation Safety Board said that he had a “constructive conversation” with Tesla CEO Elon Musk as the agency probes a recent fatal crash involving the firm’s semi-autonomous vehicles. Markets are paying close attention to earnings reports this week. The first major test of earnings season will come later this week after several key U.S. banks report earnings. JPMorgan Chase & Co. (NYSE: JPM), Citigroup Inc. (NYSE: C), and Wells Fargo & Co.(NYSE: WFC) will all report earnings on Friday morning. Look for additional earnings reports from Jamba Inc. (Nasdaq: JMBA), MSC Industrial Direct Co. Inc.(NYSE: MSM), AZZ Inc.(NYSE: AZZ), and Healthcare Services Group Inc. (Nasdaq: HCSG).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

Top 10 High Tech Stocks To Buy Right Now: CM Finance Inc(CMFN)

Advisors’ Opinion:

  • [By Max Byerly]

    CM Finance (NASDAQ: CMFN) is one of 35 publicly-traded companies in the “Investors, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare CM Finance to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, risk, institutional ownership and profitability.

Top 10 High Tech Stocks To Buy Right Now: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 High Tech Stocks To Buy Right Now: PulteGroup, Inc.(PHM)

Advisors’ Opinion:

  • [By JJ Kinahan]

    Next week is big for housing numbers. March existing home sales figures are scheduled for  Monday and new home sales for March along with the February S&P Case-Shiller Home Price Index on Tuesday. As for homebuilders, Pulte Group, Inc. (NYSE: PHM) is scheduled to report  Q1 results Tuesday, and D.R. Horton Inc (NYSE: DHI) is scheduled to report fiscal Q2 numbers on Thursday. The industry already has seen strong Q1 results from Lennar Corporation (NYSE: LEN), and housing starts and building permits in March rose more than expected. These results, as well as those and the economic data from next week could provide clues for the industry going forward. After NVR, Inc. (NYSE: NVR) reports results this morning, Meritage Homes Corp. (NYSE: MTH) releases its Q1 results April 25. We’ll have to wait until next month for some of the other homebuilders, as well as from home improvement companies Home Depot, Inc. (NYSE: HD) and Lowe’s Companies Inc (NYSE: LOW), before we get a more complete snapshot of the housing market.

  • [By Rich Smith]

    No fewer than eight separate analysts raised their price targets on shares of PulteGroup (NYSE:PHM) today, and two of them upgraded the stock, according to StreetInsider.com (subscription required). What’s got Wall Street so excited about Pulte this morning? Let’s find out.

  • [By The Ticker Tape]

    D.R. Horton and PulteGroup (PHM) are expected to report Q2 earnings on April 20th. Both companies beat analyst’s revenue and earnings expectations last quarter. Looking at Figure 1 below, all three of the major U.S. homebuilders have outperformed the S&P 500 year-to-date.

  • [By Peter Graham]

    A long term performance chart shows KB Home along with large cap D.R. Horton, Inc (NYSE: DHI) and mid capsLennar Corporation (NYSE: LEN) and PulteGroup, Inc (NYSE: PHM) somewhat range bound or volatile for the past four years:

  • [By ]

    4. PulteGroup (NYSE: PHM)
    The technical chart of this $8 billion market cap builder mirrors that of Toll Brothers.

    While the stock is off 12% this year, new orders have jumped, the backlog is soaring, and sales have grown double digits annually for the last four years.

Top 10 High Tech Stocks To Buy Right Now: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Bovie Medical Corporation (NYSE: BVX) were down 20 percent to $2.11. Bovie Medical reported a Q1 loss of $0.06 per share on sales of $8.4 million.

Top 10 High Tech Stocks To Buy Right Now: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Paul Ausick]

    Curis Inc. (NASDAQ: CRIS) matched a 52-week low of $0.88 set Friday. The 52-week high is $3.48. Volume was about 4 million, four times the daily average of around 1 million. The drugmaker had no specific news Monday.

Top 10 High Tech Stocks To Buy Right Now: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By George Budwell, Rich Smith, and Matthew DiLallo]

    With this question in mind, we asked three of our contributors which stocks they recommend to buy and hold for the next 20 years. They suggestedBioMarin Pharmaceutical (NASDAQ:BMRN), Enterprise Products Partners (NYSE:EPD), andLockheed Martin (NYSE:LMT). Below, they discuss why they chose these particular stocks, and why investors with a long-term outlook may want to consider adding them to their portfolios right now.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By Joseph Griffin]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get BioMarin Pharmaceutical alerts:

    BioMarin Pharmaceutical (BMRN) Director Sells $318,750.00 in Stock (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) BioMarin Pharmaceutical’s (BMRN) “Outperform” Rating Reiterated at BMO Capital Markets (americanbankingnews.com) Three healthcare stocks driving the gene therapy momentum (ca.finance.yahoo.com) 4 Red-Hot Biotech Stocks to Buy Before Earnings (247wallst.com)

    Shares of BioMarin Pharmaceutical stock traded down $1.32 on Friday, hitting $82.30. 2,278,721 shares of the company’s stock traded hands, compared to its average volume of 1,207,934. BioMarin Pharmaceutical has a one year low of $75.81 and a one year high of $100.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.70 and a quick ratio of 2.12. The firm has a market cap of $14,490.73, a price-to-earnings ratio of -122.84 and a beta of 1.69.

  • [By Chris Lange]

    Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is expected to report its most recent quarterly results on February 22. The consensus estimates from Thomson Reuters are calling for a net loss of $0.24 per share on $357.49 million in revenue. The same period of last year had a net loss of $0.53 per share and $300.09 million in revenue. Shares of BioMarin were last seen at $84.98, with a consensus price target of $110.32 and a 52-week range of $78.50 to $100.51.

Top 10 High Tech Stocks To Buy Right Now: Lumber Liquidators Holdings, Inc(LL)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) is scheduled for before the market opens onTuesday (February 21th). Lumber Liquidators Holdingshad been ahighflying stock until the middle of 2013 when shares were hit be allegations that the companys flooring products contained illegal levels of formaldehyde. Shares then took another hit on reports that the Department of Homeland Security andthe USFish and Wildlife Servicehad executed a sealed court-issuedsearch/raid on theheadquarters for possible sourcing violations.Lumber Liquidators Holdingslater won a favorable ruling in a California lawsuit filed under the state’s Proposition 65 covering cancer-causing chemicals and agreed to pay $2.5 million (without admitting wrongdoing) to settle a civil matter with the California Air Resources Board.

  • [By Peter Graham]

    Small cap hardwood flooring stockLumber Liquidators Holdings Inc (NYSE: LL) reportedQ2 2017 earnings before the market opened this morning with better than expected earnings sending shares soaring as the Company went into earnings with short interest of 24.68% according to Highshortinterest.com. Net sales increased10.7% to $263.5 million as net sales in comparable stores increased 8.8% driven by a 5.3% increase in the number of customers invoiced and a 3.5% increase in the average sale. Merchandise sales in comparable stores grew 6.1% in the quarter whilenet sales in non-comparable stores increased $4.4 million. The Company did not open any stores during the second quarter of 2017 with the total store count remaining at 385 as of June 30, 2017. Net income was $4.5 million versusa net loss of $12.2 million for the first profit in the wake of a 2015 “60 Minutes” report that claimed the Companys laminate flooring contained high levels of cancer-causing formaldehyde.

  • [By Daniel Miller]

    If you remember about a year ago, the Centers for Disease Control and Prevention let the world know that consumers who had purchased the China-produced flooring from Lumber Liquidators Holdings (NYSE:LL) were roughly three times more likely to fall ill with cancer. That rate was much higher than earlier calculations following the 2015 broadcast by CBS’ 60 Minutes.The stock shed much of its value since the 2015 airing, but rebounded 17% on Tuesday after it reported a narrower-than-expected loss during the fourth quarter, offering investors a slight amount of hope going forward.

  • [By Ethan Ryder]

    Lumber Liquidators Holdings (NYSE:LL) – Oppenheimer upped their FY2018 earnings per share (EPS) estimates for shares of Lumber Liquidators in a report issued on Tuesday, May 1st. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will post earnings of $0.80 per share for the year, up from their prior estimate of $0.70.

Top 10 High Tech Stocks To Buy Right Now: PCM, Inc.(PCMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    PCM (NASDAQ: PCMI) is one of 20 publicly-traded companies in the “Catalog & mail-order houses” industry, but how does it compare to its competitors? We will compare PCM to similar companies based on the strength of its dividends, institutional ownership, valuation, profitability, risk, analyst recommendations and earnings.

  • [By Lisa Levin]

    PCM Inc (NASDAQ: PCMI) was down, falling around 26 percent to $14.63. PCM reported Q2 adjusted earnings of $0.47 per share on sales of $560.1 million.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Lisa Levin]

    Thursday morning, the information technology shares gained 1.72 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 13 percent.

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)

Top 10 High Tech Stocks To Buy Right Now: Western Union Company (WU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    You don’t need to be an expert technical trader to figure out the price action in shares of $10 billion payment services stock Western Union (WU) . Instead, the price action is more or less as simple as it gets. Since January, Western Union has been a “buy the dips stock”, bouncing its way higher in a well-defined uptrend. And shares are showing traders another buyable dip this week.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Western Union (WU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer was bearish on Tower Semiconductor (TSEM) , Western Union (WU) , Huntington Ingalls (HII) and (LX) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Brian Mathews]

    Western Union Co. (NYSE: WU) is the leading independent provider of consumer money transfer services. After a rough couple of years and dealing with compliance and regulatory issues, WU has finally weathered the storm. Market share has stabilized and revenues have been slowly growing. One of Western Union’s strengths is its size in the industry. The money-transfer business is highly scalable because the incremental costs of processing additional transactions are minimal. This allows WU to have operating margins that are twice as large as its closest competitor. Also, since WU is a highly recognizable brand, consumers flock to use its services in comparison to its peers. Western Union submitted a bid to buy the Australian company OzForex. If this deal goes through, it will provide additional scale to WU, especially to a market clientele that is more affluent. With the troubling times behind the company and expansion on the horizon, expect WU stock to appreciate to $24.

  • [By Paul Ausick]

    The Western Union Co. (NYSE: WU) dropped 2.9% Tuesday to post a new 52-week low of $17.38. Shares closed at $18.93 on Monday and the stock’s 52-week high is $22.21. Volume was more nearly 10% above the daily average of around 6 million shares. The company’s stock was hit following an announcement from Walmart of a worldwide money transfer service.

  • [By Ben Levisohn]

    Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).

    Agence France-Presse/Getty Images

    Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.

    Normally, two competitors linking up to take on the dominant player in the industry might be considered bad news. BTIG’s Mark Palmer and Giuliano Bolognaexplain why the Western Union reaction”makes sense”:

    While the surge in shares of MoneyGram (MGI, Not Rated) in response to the announcement by Euronet Worldwides (EEFT, Not Rated) that it had offered to buy the company for $15.20 per share in cash was easy to understand the bid trumped the bid of $13.25 per share that MoneyGram received from Alibaba (BABA) affiliate Ant Financial in late January what may have been surprising to some was the positive reaction of shares of MGI remittance competitor Western Union (WU, Buy, $23 PT) to the news.

    With that said, we believe the uptick in WU shares makes some sense insofar as the competitive threat posed by EEFT may be perceived as less imposing than that represented by Ant, especially following reports in February that the latter was planning to raise as much as $3bn to fund global investments.

    We also believe the second bid for MGI serves to underline the attractiveness and potential of the global remittance space, an industry in which WU is the clear leader. Moreover, we think the bid may have given rise to the notion that WU could be an acquisition candidate for another deep-pocketed firm that could lever off its global footprint and the strength of its brand.

    Western Union’s market capitalization rose to $9.8 billion today, from $9.4 billion yesterday. It reported net income of $253 million on sales of $5.4 billion in